![]() |
|
![]() |
Reglan A Reglan attorney will contact you within one business day, once you fill out a Reglan claim evaluation. Fill out a Reglan claim evaluation. Reglan is a drug that has been prescribed by doctors to treat gastrointestinal problems in adults and children for a short course of treatment no longer than 12 weeks. This drug is also generically known as Metoclopramide, and also marketed as Octamide, Maxolon, Degan, Maxeran, Primperan, and Pylomid. One of the most common uses for Reglan is to treat GERD (Gastrointestinal Reflux Disease), but it is also used to suppress symptoms of gastroparesis, heartburn, gastroesophageal reflux and delayed gastric emptying in both adults and children. These drugs work by speeding up the movement of the stomach muscles, which increases the rate that the stomach empties into the intestines. Recent warnings by the Federal Drug Administration are linked to the problems of use of the drug beyond the recommended term of 4 to 12 weeks. Use of this drug for longer than 3 months has been linked to Tardive Dyskinesia which is a serious neurological disorder. Movement disorders and Tardive Dyskinesia have been the most common side effects which have been reported with prolonged use of Reglan. There is no cure for Tardive Dyskinesia and the majority of reports on this disorder indicate that some of the side effects have led to irreversible conditions. Some of the side effects and symptoms of Tardive Dyskinesia and movement disorders overlap and may be displayed as follows:
Lawsuit Information Many Reglan lawsuits have already been filed where claimants argue that the manufacturer, Wyeth, and its sales representatives, knew about, and encouraged, long term courses of treatment of Reglan and Metoclopramide to patients with chronic conditions. Claims that Reglan patients who were prescribed the drug, and later developed TD, indicate that the drug companies did not adequately warn the doctors and their patients of the association between Reglan and Metoclopramide and TD. The drug companies also failed to adequately warn the doctors and patients about the heightened danger of developing TD from use of the drug for more than maximum treatment course of 12 weeks. There are also allegations that the manufacturers of Reglan and Metoclopramide failed to adequately study and investigate the drug fully or warn about the potential side effects associated with use of the drug. In February of 2009, the FDA issued a “Black Box Warning” for Reglan and required the drug label be revised. Prior to the “Black Box Warning”, Reglan and Metoclopramide were sold for decades without accurate safety warnings and the prescriptions were for a longer course of treatment than 12 weeks. Lawsuits have been filed alleging that the manufacturers of Reglan and Metoclopramide failed to adequately study and investigate the drug fully or warn about the potential side effects associated with the use of this drug. Reglan Claim Evaluation Please enter all required information to complete your Reglan claim evaluation. Reglan / Metoclopramide is also marketed under the names Octamide, Maxolon, Degan, Maxeran, Primperan, and Pylomid. The submission of information to Funk & Associates (“The Firm”) or one of its attorneys does not create an attorney-client relationship, and the receipt of said information does not constitute an attorney-client relationship. This website presents general information which is not intended to be legal advice, nor should you consider it as such. Contacting Funk & Associates does not, and should not, prohibit you in any way from seeking legal advice regarding this or any other matter. This Firm makes no representations, material or implied, of any statute of limitations which may or may not exist. |
|
| Funk & Associates © 2009-2010. Principal Office – Austin, Texas.
Licensed by the Supreme Court of Texas. |